Euclidean Technologies Management’s HCA Healthcare HCA Stock Holding History

Euclidean Technologies Management’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-6,343	Closed	-$1.31M	–	92
2021 Q2	$1.31M	Hold	6,343	–	–	1.05%	50
2021 Q1	$1.2M	Hold	6,343	–	–	1.04%	51
2020 Q4	$1.04M	Hold	6,343	–	–	1.1%	51
2020 Q3	$791K	Sell	6,343 -1,845	-23%	-$228K	1%	51
2020 Q2	$795K	Sell	8,188 -4,393	-35%	-$457K	1.12%	48
2020 Q1	$1.13M	Hold	12,581	–	–	1.87%	26
2019 Q4	$1.86M	Sell	12,581 -3,000	-19%	-$403K	1.93%	30
2019 Q3	$1.88M	Hold	15,581	–	–	1.76%	33
2019 Q2	$2.11M	Hold	15,581	–	–	1.98%	21
2019 Q1	$2.03M	Sell	15,581 -900	-5%	-$121K	1.88%	28
2018 Q4	$2.05M	Hold	16,481	–	–	2.13%	11
2018 Q3	$2.29M	Sell	16,481 -7,500	-31%	-$934K	2.02%	16
2018 Q2	$2.46M	Hold	23,981	–	–	2.29%	2
2018 Q1	$2.33M	Hold	23,981	–	–	2.29%	3
2017 Q4	$2.11M	Sell	23,981 -826	-3%	-$66.4K	2.07%	16
2017 Q3	$1.97M	Sell	24,807 -900	-4%	-$72.4K	1.89%	28
2017 Q2	$2.24M	Buy	+25,707	New	+$2.17M	2.16%	13

Other funds holding HCA

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Euclidean Technologies Management's HCA Position: Q3 2021 in Review

Euclidean Technologies Management sold out of HCA Healthcare (HCA) in Q3 2021, closing a stake of 6,343 shares — an estimated $1.31M sold.

Euclidean Technologies Management first reported a position in HCA in Q2 2017 and held it in 17 quarters. The position peaked at $2.46M in Q2 2018. 885 funds tracked by Wall St. Rank hold HCA as of Q3 2021.

Euclidean Technologies Management reported no remaining HCA Healthcare position as of Q3 2021 after selling out during the quarter.
Euclidean Technologies Management sold 6,343 HCA Healthcare shares in Q3 2021, an estimated $1.31M.
Euclidean Technologies Management first reported a position in HCA Healthcare in Q2 2017 and held it in 17 quarters.
Euclidean Technologies Management's HCA Healthcare position peaked at $2.46M in Q2 2018.
885 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2021.

Based on Euclidean Technologies Management's 13F filing for Q3 2021, filed 2 Nov 2021.